Information

Home Information
  • Feb 06, 2025

Analysis-Trump's aid cuts imperil emerging market investment cash

The United States' decision to freeze and potentially scrap its core aid agency jolted countries receiving its funding and could make it harder for emerging economies to attract private cash, investors said. The U.S. Agency for International Development (USAID) not only disbursed $44 billion in fiscal 2023, but anchors private investment in everything from healthcare to small businesses, and underpins the creditworthiness of bigger emerging markets borrowing money on sovereign debt markets.

  • Feb 06, 2025

IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year revenue guidance of $15.93 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $3.12 per share was in line with analysts’ consensus estimates.

  • Feb 06, 2025

Under Armour (NYSE:UAA) Delivers Impressive Q4, Stock Soars

Athletic apparel company Under Armour (NYSE:UAA) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 5.7% year on year to $1.40 billion. Its non-GAAP profit of $0.08 per share was significantly above analysts’ consensus estimates.

  • Feb 06, 2025

Philip Morris (NYSE:PM) Surprises With Q4 Sales, Stock Soars

Tobacco company Philip Morris International (NYSE:PM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.3% year on year to $9.71 billion. Its non-GAAP profit of $1.55 per share was 3.4% above analysts’ consensus estimates.

  • Feb 06, 2025

Fed releases 2025 stress test scenarios

The stress test, which will include 22 banks compared to last year’s 32, will feature two added hypothetical elements for the Fed’s “exploratory analysis” of the banking system.

  • Feb 06, 2025

Peloton’s (NASDAQ:PTON) Q4 Sales Beat Estimates, Stock Jumps 12.5%

Exercise equipment company Peloton (NASDAQ:PTON) announced better-than-expected revenue in Q4 CY2024, but sales fell by 9.4% year on year to $673.9 million. On the other hand, next quarter’s revenue guidance of $615 million was less impressive, coming in 6% below analysts’ estimates. Its GAAP loss of $0.24 per share was 25.9% below analysts’ consensus estimates.

  • Feb 06, 2025

Tapestry (NYSE:TPR) Posts Better-Than-Expected Sales In Q4, Stock Jumps 14.6%

Luxury fashion conglomerate Tapestry (NYSE:TPR) announced better-than-expected revenue in Q4 CY2024, with sales up 5.3% year on year to $2.20 billion. The company’s full-year revenue guidance of $6.85 billion at the midpoint came in 1.4% above analysts’ estimates. Its GAAP profit of $1.38 per share was 12.7% below analysts’ consensus estimates.

Popular Post